CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-20 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,612,032 | 1,612,032 | ||
| 2025-02-20 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,074,696 | 1,074,696 | ||
| 2025-01-17 | Lunger John Chief Patient Supply Officer | Sale | −5,584 | $0.58 | $3K | 7,510 |
| 2025-01-15 | Lunger John Chief Patient Supply Officer | Sale | −9,803 | $0.57 | $6K | 13,756 |
| 2025-01-13 | Lunger John Chief Patient Supply Officer | Sale | −4,268 | $0.59 | $3K | 5,845 |
| 2025-01-13 | Lunger John Chief Patient Supply Officer | Sale | −5,471 | $0.59 | $3K | 7,623 |
| 2024-01-17 | Lunger John Chief Patient Supply Officer | Sale | −5,309 | $0.67 | $4K | 7,785 |
| 2024-01-17 | Lunger John Chief Patient Supply Officer | Sale | −12,805 | $0.67 | $9K | 19,015 |
| 2024-01-16 | Lunger John Chief Patient Supply Officer | Sale | −4,681 | $0.79 | $4K | 7,023 |
| 2024-01-15 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +2,544,432 | 2,544,432 | ||
| 2024-01-15 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +565,416 | 565,416 | ||
| 2024-01-12 | Lunger John Chief Patient Supply Officer | Sale | −5,220 | $0.85 | $4K | 7,874 |
| 2024-01-11 | Lunger John Chief Patient Supply Officer | Sale | −4,009 | $0.84 | $3K | 6,104 |
| 2023-08-01 | Lunger John Chief Patient Supply Officer | Sale | −3,096 | $0.91 | $3K | 4,718 |
| 2023-01-17 | Lunger John Chief Patient Supply Officer | Sale | −4,440 | $1.86 | $8K | 7,264 |
| 2023-01-17 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | ||
| 2023-01-17 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | ||
| 2023-01-17 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +190,920 | 190,920 | ||
| 2023-01-12 | Lunger John Chief Patient Supply Officer | Sale | −4,973 | $1.71 | $8K | 8,121 |
| 2023-01-11 | Lunger John Chief Patient Supply Officer | Sale | −3,843 | $1.75 | $7K | 6,270 |
Page 1 of 3 · 43 trades